Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
BioXcel Therapeutics, Inc. - Common Stock
(NQ:
BTAI
)
1.840
+0.040 (+2.22%)
Streaming Delayed Price
Updated: 10:35 AM EST, Feb 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,572
Open
1.800
Bid (Size)
1.810 (1)
Ask (Size)
1.840 (5)
Prev. Close
1.800
Today's Range
1.770 - 1.840
52wk Range
0.1600 - 3.500
Shares Outstanding
42,748,364
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Which stocks are experiencing notable movement on Monday?
February 10, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
February 10, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Performance
YTD
+369.39%
+369.39%
1 Month
+403.28%
+403.28%
3 Month
+306.72%
+306.72%
6 Month
+204.23%
+204.23%
1 Year
-44.58%
-44.58%
More News
Read More
The market is filled with gapping stocks in Monday's session.
February 10, 2025
Via
Chartmill
What's Next: BioXcel Therapeutics's Earnings Preview
November 13, 2024
Via
Benzinga
BioXcel Therapeutics's Earnings Outlook
March 11, 2024
Via
Benzinga
Wondering what's happening in today's after-hours session?
February 07, 2025
Via
Chartmill
Which stocks are moving on Thursday?
February 06, 2025
Via
Chartmill
Thursday's session: top gainers and losers
February 06, 2025
Via
Chartmill
Thursday's session: gap up and gap down stocks
February 06, 2025
Via
Chartmill
What's going on in today's after hours session
February 04, 2025
Via
Chartmill
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 24, 2025
Via
Benzinga
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
December 17, 2024
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 22, 2024
Via
Benzinga
BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
Via
InvestorPlace
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study
June 25, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 25, 2024
Via
InvestorPlace
BTAI Stock Earnings: BioXcel Therapeutics Misses EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
AI Surge Has Ended: All 7 AI Stock Categories Declined This Week
April 13, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
March 23, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Earnings Scheduled For March 12, 2024
March 12, 2024
Via
Benzinga
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
March 07, 2024
Via
InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Via
Talk Markets
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 27, 2024
Via
Benzinga
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.